177 related articles for article (PubMed ID: 35405778)
1. [Treatment and prognosis of primary ocular adnexal extranodal marginal zone mucosa-associated lymphoid tissue lymphoma: a report from a single center].
Li X; Ye J; Yang L; Wei LQ; Cong J; Yao N; Yang J; Wang JW
Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):209-214. PubMed ID: 35405778
[No Abstract] [Full Text] [Related]
2. Long-term survival outcomes of patients with primary ocular adnexal MALT lymphoma: A large single-center cohort study.
Liang Y; Fu RY; Liu XL; Liu XD; Piao YS; Ma JM; Wang L
Cancer Med; 2023 Feb; 12(3):2514-2523. PubMed ID: 35906828
[TBL] [Abstract][Full Text] [Related]
3. Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study.
Oh SY; Kim WS; Kang HJ; Lee JH; Huh SJ; Kim SJ; Yoon DH; Hong JY; Lee WS; Kim HJ; Won JH; Park BB; Lee SI; Suh C
Ann Hematol; 2018 Oct; 97(10):1851-1857. PubMed ID: 29947974
[TBL] [Abstract][Full Text] [Related]
4. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
5. Orbital and ocular adnexal Mucosa-Associated Lymphoid Tissue (MALT) lymphomas: a single-center 10-year experience.
Smiljanic M; Milosevic R; Antic D; Andjelic B; Djurasinovic V; Todorovic M; Bila J; Bogdanovic A; Mihaljevic B
Med Oncol; 2013 Dec; 30(4):722. PubMed ID: 24026660
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of tumor-infiltrating FOXP3+ T cells in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Kim KH; Kim TM; Go H; Kim WY; Jeon YK; Lee SH; Kim DW; Khwarg SI; Kim CW; Heo DS
Cancer Sci; 2011 Nov; 102(11):1972-6. PubMed ID: 21812857
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
Lee SE; Paik JS; Cho WK; Choi BO; Lee SN; Jung SE; Park KS; Kang CS; Kim SH; Yang SW; Cho SG
Am J Hematol; 2011 Mar; 86(3):262-6. PubMed ID: 21328439
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
[TBL] [Abstract][Full Text] [Related]
10. Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: A retrospective study.
Mizuhara K; Kobayashi T; Nakao M; Takahashi R; Kaneko H; Shimura K; Hirakawa K; Uoshima N; Wada K; Kawata E; Isa R; Fujino T; Tsukamoto T; Mizutani S; Shimura Y; Yoneda A; Watanabe A; Sotozono C; Kuroda J
Cancer Med; 2023 Feb; 12(3):3134-3144. PubMed ID: 36097396
[TBL] [Abstract][Full Text] [Related]
11. [Chinese expert consensus on the diagnosis and management of ocular adnexal extranodal marginal zone mucosa-associated lymphoid tissue lymphoma (2023 edition)].
; ; ; ;
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):296-303. PubMed ID: 38303512
[TBL] [Abstract][Full Text] [Related]
12. [The clinical features and outcomes in 21 patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma].
Ning F; Ye J; Wei LQ; Li X; Wang JW
Zhonghua Nei Ke Za Zhi; 2012 Oct; 51(10):784-7. PubMed ID: 23290977
[TBL] [Abstract][Full Text] [Related]
13. Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients.
Kiesewetter B; Lukas J; Kuchar A; Mayerhoefer ME; Streubel B; Lagler H; Müllauer L; Wöhrer S; Fischbach J; Raderer M
PLoS One; 2014; 9(7):e104004. PubMed ID: 25077481
[TBL] [Abstract][Full Text] [Related]
14. The clinical characteristics and treatment results of ocular adnexal lymphoma.
Woo JM; Tang CK; Rho MS; Lee JH; Kwon HC; Ahn HB
Korean J Ophthalmol; 2006 Mar; 20(1):7-12. PubMed ID: 16768184
[TBL] [Abstract][Full Text] [Related]
15. Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type of the ocular adnexa: retrospective single institution review of 95 patients.
Lim SH; Kang M; Son J
Indian J Ophthalmol; 2011; 59(4):273-7. PubMed ID: 21666310
[TBL] [Abstract][Full Text] [Related]
16. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type.
White WL; Ferry JA; Harris NL; Grove AS
Ophthalmology; 1995 Dec; 102(12):1994-2006. PubMed ID: 9098307
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy alone for stage IE ocular adnexal mucosa-associated lymphoid tissue lymphomas: long-term results.
Niwa M; Ishikura S; Tatekawa K; Takama N; Miyakawa A; Kubota T; Kato E; Shibamoto Y
Radiat Oncol; 2020 Jan; 15(1):25. PubMed ID: 32000814
[TBL] [Abstract][Full Text] [Related]
18. Risk potentiality of frontline radiotherapy associated cataract in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Cho WK; Lee SE; Paik JS; Cho SG; Yang SW
Korean J Ophthalmol; 2013 Aug; 27(4):243-8. PubMed ID: 23908569
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Selection and Long-term Clinical Outcomes Between Chemotherapy and Radiotherapy as Primary Therapeutic Modality for Ocular Adnexal MALT Lymphoma.
Jeon YW; Yang HJ; Choi BO; Jung SE; Park KS; O JH; Yang SW; Cho SG
EClinicalMedicine; 2018; 4-5():32-42. PubMed ID: 31193655
[TBL] [Abstract][Full Text] [Related]
20. Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis.
Masuda Y; Takeuchi K; Kodama T; Fujisaki T; Imaizumi Y; Otsuka E; Ozaki S; Hasebe S; Yakushijin Y
Int J Clin Oncol; 2019 Dec; 24(12):1620-1628. PubMed ID: 31172332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
